Fenbendazole 500 mg, originally developed as a veterinary antiparasitic medication, has recently gained attention for its potential use in humans. While it is primarily approved for deworming animals like dogs, cats, and livestock, some individuals have explored its off-label use to treat intestinal parasites and other emerging health concerns.
In humans, Fenbendazole is believed to work by disrupting the metabolism of parasitic worms, depriving them of glucose and eventually killing them. It may be considered for use in treating infections caused by roundworms, hookworms, whipworms, and certain tapeworms. Anecdotal reports also suggest that Fenbendazole may have potential benefits in cancer management, although there is currently no conclusive clinical evidence supporting these claims.
People who consider using
Fenbendazole 500 mg for human use should be cautious. It is not FDA-approved for human consumption, and incorrect dosing could lead to side effects such as nausea, abdominal pain, or allergic reactions.
